Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Aberrant Crypt Foci
Ketoprofen-inhibited N-acetyltransferase activity and gene expression in human colon tumor cells.
Adenomatous Polyposis Coli
Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis.
Asthma
Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts.
Astrocytoma
Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
Autoimmune Diseases
Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Bone Diseases, Metabolic
The Prevalence of Rib Fractures Incidentally Identified by Chest Radiograph among Infants and Toddlers.
Brain Neoplasms
Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
Breast Neoplasms
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1.
Breast Neoplasms
Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
Breast Neoplasms
Arylamine N-acetyltransferase 1 regulates expression of matrix metalloproteinase 9 in cancer cells: role of HIF1-?.
Breast Neoplasms
Arylamine N-acetyltransferase activities in human breast cancer tissues.
Breast Neoplasms
Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.
Breast Neoplasms
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
Breast Neoplasms
From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Breast Neoplasms
Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.
Breast Neoplasms
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Breast Neoplasms
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
Breast Neoplasms
Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
Breast Neoplasms
Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer.
Breast Neoplasms
Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
Breast Neoplasms
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1.
Breast Neoplasms
Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study.
Breast Neoplasms
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
Breast Neoplasms
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker.
Breast Neoplasms
Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells.
Breast Neoplasms
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
Breast Neoplasms
Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1.
Carcinogenesis
Arylamine N-acetyltransferase: a possible promoter in Helicobacter pylori-related gastric carcinogenesis.
Carcinogenesis
Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population.
Carcinogenesis
Role of aromatic amine acetyltransferase in human colorectal cancer.
Carcinoma
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese.
Carcinoma
Paclitaxel (taxol) inhibits the arylamine N-acetyltransferase activity and gene expression (mRNA NAT1) and 2-aminofluorene-DNA adduct formation in human bladder carcinoma cells (T24 and TSGH 8301).
Carcinoma, Transitional Cell
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese.
Cataract
NAT2 slow acetylator function as a risk indicator for age-related cataract formation.
Chemical and Drug Induced Liver Injury
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.
Cholangiocarcinoma
Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
Cholangiocarcinoma
Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells.
Coinfection
Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests.
Colonic Neoplasms
Inhibition of N-acetyltransferase activity and gene expression in human colon cancer cell lines by diallyl sulfide.
Colorectal Neoplasms
Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients.
Colorectal Neoplasms
Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Colorectal Neoplasms
Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Congenital Abnormalities
Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.
Cystic Fibrosis
Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients.
Cystic Fibrosis
Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.
Dermatitis, Allergic Contact
Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis.
Diabetes Mellitus, Type 1
Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
Drug-Related Side Effects and Adverse Reactions
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Drug-Related Side Effects and Adverse Reactions
Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Drug-Related Side Effects and Adverse Reactions
Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice.
Drug-Related Side Effects and Adverse Reactions
Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.
Endometriosis
Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis.
Endometriosis
Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
Endometriosis
Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis.
Glioblastoma
Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
Head and Neck Neoplasms
Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.
Laryngeal Neoplasms
Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
Laryngeal Neoplasms
Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.
Latent Tuberculosis
Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents.
Leukemia
Aloe-emodin inhibited N-acetylation and DNA adduct of 2-aminofluorene and arylamine N-acetyltransferase gene expression in mouse leukemia L 1210 cells.
Leukemia
Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells.
Leukemia
Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells.
Leukemia
Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in human promyelocytic leukemia cells.
Leukemia
Leukemia inhibitory factor decreases the arylamine N-acetyltransferase activity in human cumulus granulosa cells.
Leukemia
Luteolin-inhibited arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human and mouse leukemia cells.
Leukemia
Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells.
Leukemia
The effect of paclitaxel on gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in human leukemia HL-60 cells.
Leukemia L1210
Aloe-emodin inhibited N-acetylation and DNA adduct of 2-aminofluorene and arylamine N-acetyltransferase gene expression in mouse leukemia L 1210 cells.
Leukemia L1210
Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells.
Liver Cirrhosis
Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.
Lung Neoplasms
Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
Lung Neoplasms
Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
Lung Neoplasms
Polymorphisms in the N acetyltransferase 1 NAT1 gene and lung cancer risk in a minority population.
Lung Neoplasms
Study design and genetic susceptibility factors in the risk assessment of chemical carcinogens.
Lupus Erythematosus, Systemic
Genotypes of polymorphic arylamine N-acetyltransferase in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosus.
Lymphoma, Non-Hodgkin
N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Melanoma
Serotoninergic system in hamster skin.
Methemoglobinemia
The role of para-aminophenol in acetaminophen-induced methemoglobinemia in dogs and cats.
Neoplasms
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1.
Neoplasms
A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.
Neoplasms
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Neoplasms
Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
Neoplasms
Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1.
Neoplasms
Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
Neoplasms
Arylamine N-acetyltransferase 1 regulates expression of matrix metalloproteinase 9 in cancer cells: role of HIF1-?.
Neoplasms
Arylamine N-acetyltransferase 1: a novel drug target in cancer development.
Neoplasms
Arylamine N-acetyltransferase activity and 2 aminofluorene-DNA adducts formation in rat glial tumor cells.
Neoplasms
Assessment of exposure and susceptibility to aromatic amine carcinogens.
Neoplasms
Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.
Neoplasms
Cellular distribution of N-acetyltransferase activity in the rat small intestine.
Neoplasms
Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism.
Neoplasms
Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.
Neoplasms
Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population.
Neoplasms
Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin ?V.
Neoplasms
Effects of (-)-menthol on arylamine N-acetyltransferase activity in human liver tumor cells.
Neoplasms
Effects of 5-methoxypsoralen (5-MOP) on arylamine N-acetyltransferase activity in the stomach and colon of rats and human stomach and colon tumor cell lines.
Neoplasms
Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells.
Neoplasms
Effects of carmustine and lomustine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in rat glial tumor cells.
Neoplasms
Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
Neoplasms
Effects of ibuprofen on arylamine N-acetyltransferase activity in human colon tumor cells.
Neoplasms
Effects of luteolin on arylamine N-acetyltransferase activity in human liver tumour cells.
Neoplasms
Effects of the garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human colon tumour cells.
Neoplasms
Effects of vitamin C on arylamine N-acetyltransferase activity in human liver tumor cells.
Neoplasms
Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.
Neoplasms
Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.
Neoplasms
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Neoplasms
Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.
Neoplasms
Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
Neoplasms
Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Neoplasms
Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice.
Neoplasms
Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
Neoplasms
Immunohistochemical, ultrastructural, biochemical and in vitro studies of a pineocytoma.
Neoplasms
Implication of arylamine N-acetyltransferase (NAT2) polymorphism on levels of tumour markers CEA, AFP, CA 125, CA 19.9, and CA 15.3.
Neoplasms
Inhibition of N-acetyltransferase activity and DNA-2-aminofluorene adducts by glycyrrhizic acid in human colon tumour cells.
Neoplasms
Inhibitory actions of sulindac on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Neoplasms
Ketoprofen-inhibited N-acetyltransferase activity and gene expression in human colon tumor cells.
Neoplasms
Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complex.
Neoplasms
Modulation of Human Arylamine N-Acetyltransferase 1 Activity by Lysine Acetylation: Role of p300/CREB-Binding Protein and Sirtuins 1 and 2.
Neoplasms
Molecular genetics of cancer susceptibility.
Neoplasms
Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
Neoplasms
Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation.
Neoplasms
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.
Neoplasms
Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway.
Neoplasms
Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1.
Neoplasms
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
Neoplasms
The effect of paclitaxel on 2-aminofluorene-DNA adducts formation and arylamine N-acetyltransferase activity and gene expression in human lung tumor cells (A549).
Neoplasms
The effect of sulindac on arylamine N-acetyltransferase activity in Pseudomonas aeruginosa.
Neoplasms
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
Neoplasms
Vitamin C inhibited DNA adduct formation and arylamine N-acetyltransferase activity and gene expression in rat glial tumor cells.
Nocardia Infections
Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
Osteosarcoma
PCR and flow cytometric analysis of paclitaxel-inhibited arylamine N-acetyltransferase activity and gene expression in human osteogenic sarcoma cells (U-2 OS).
Peptic Ulcer
Aloe-emodin effects on arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori.
Peptic Ulcer
Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Ibuprofen affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Inhibitory actions of ellagic acid on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Inhibitory actions of emodin on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Inhibitory actions of glycyrrhizic acid on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Inhibitory actions of sulindac on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients.
Peptic Ulcer
Shikonin inhibits the growth and N-acetylation of 2-aminofluorene in Helicobacter pylori from ulcer patients.
Peptic Ulcer
The effects of vitamin E on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients.
Prostatic Hyperplasia
Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator human benign prostatic hyperplasia tissues.
Prostatic Neoplasms
Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.
Prostatic Neoplasms
Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
Prostatic Neoplasms
Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.
Renal Insufficiency, Chronic
Testicular dysfunction in experimental chronic renal insufficiency: a deficiency of nocturnal pineal N-acetyltransferase activity.
Sarcoma 37
N-acetyltransferase activity as a possible criterion in prognosing the anti-tumor effect of cyclophosphamide.
Scleroderma, Systemic
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
Spondylitis, Ankylosing
Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Starvation
Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
Triple Negative Breast Neoplasms
Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
Tuberculosis
A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases.
Tuberculosis
Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
Tuberculosis
Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
Tuberculosis
Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Tuberculosis
Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
Tuberculosis
Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Tuberculosis
Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
Tuberculosis
Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents.
Tuberculosis
Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
Tuberculosis
Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis.
Tuberculosis
Mutational and expression analysis of tbnat and its response to isoniazid.
Tuberculosis
Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
Tuberculosis
Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations.
Tuberculosis
Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Tuberculosis
Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
Urinary Bladder Neoplasms
A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.
Urinary Bladder Neoplasms
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Urinary Bladder Neoplasms
Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: an investigation in bladder cancer by interphase FISH.
Urinary Bladder Neoplasms
Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.
Urinary Bladder Neoplasms
Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Urinary Bladder Neoplasms
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Urinary Bladder Neoplasms
Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Urinary Bladder Neoplasms
Effects of aspirin on arylamine N -acetyltransferase activity and DNA adducts in human bladder tumour cells.
Urinary Bladder Neoplasms
Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells.
Urinary Bladder Neoplasms
Effects of butylated hydroxyanisole and butylated hydroxytoluene on DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumour cells.
Urinary Bladder Neoplasms
Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human bladder tumor cells.
Urinary Bladder Neoplasms
Ellagic [correction of ellagica] acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
Urinary Bladder Neoplasms
Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301).
Urinary Bladder Neoplasms
Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.
Urinary Bladder Neoplasms
Inheritance of acetylator genotype-dependent arylamine N-acetyltransferase in hamster bladder cytosol.
Urinary Bladder Neoplasms
Inhibition by vitamin C of DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumor cells.
Urinary Bladder Neoplasms
Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Urinary Bladder Neoplasms
Polymorphisms in xenobiotic conjugation and disease predisposition.
Urinary Bladder Neoplasms
Study design and genetic susceptibility factors in the risk assessment of chemical carcinogens.
Urinary Bladder Neoplasms
Sulindac inhibited gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in T24 human bladder tumor cells.
Vitamin A Deficiency
Regulation of the expression of serotonin N-acetyltransferase gene in Japanese quail (Coturnix japonica): II. Effect of vitamin A deficiency.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2.3.1.5 arylamine N-acetyltransferase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
